InsidersTradesSigma
Track the Hoth Therapeutics, Inc. stock price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 28 August 2025 (Attribution). Among the most active insiders: Knie Robb. All data is free.
Analysts rate Hoth Therapeutics, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Hoth Therapeutics, Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos innovadores para enfermedades de la piel. Su objetivo es proporcionar soluciones terapéuticas para mejorar la calidad de vida de los pacientes.